Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quidam: Hydroquinidine in Brugada Syndrome
NCT00927732Phase 3Terminated
- Sponsor
- CHU de Nantes
- Start
- Feb 2009
- Primary completion
- Oct 2014
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroquinidine in Brugada syndrome, sponsored by CHU de Nantes. Started Feb 2009; status: terminated.
02
Drugs
hydroquinidine
03
Conditions
Brugada syndrome
Beyond the preview
Go deeper on NCT00927732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00927732.